TickerStat.comwe like data

Cyclerion Therapeutics, Inc. (CYCN)

Price$4.25Cached quote
CYCNNasdaq
Loading local price history

Financial charts

Revenue

Total cash / debt

CashTotal debt

Financial statements

8 annual periodsNewest to oldest
20252024202320222021202020192018
Revenue$2.1M$2.0M$0$297,000$3.9M$2.3M$4.5M—
Research & development$959,000$286,000$1.5M$6.0M$37.6M$56.4M$95.1M$87.7M
Operating expenses$7.0M$5.6M$13.0M$18.8M$59.1M$83.6M$129.5M$115.3M
Operating income−$5.0M−$3.6M−$13.0M−$18.5M−$55.2M−$81.3M−$125.0M−$115.3M
Operating margin−239.78%−181.40%—−6,242.42%−1,400.18%−3,539.42%−2,774.28%—
EBITDA−$5.0M−$3.6M−$13.0M−$18.5M−$54.7M−$79.0M−$122.3M−$113.7M
EBITDA margin−239.78%−181.40%—−6,220.54%−1,388.20%−3,439.37%−2,714.38%—
Net income−$3.5M−$3.1M−$5.3M−$44.1M−$51.6M−$77.8M−$123.0M−$115.3M
Net profit margin−170.11%−152.85%—−14,841.08%−1,310.17%−3,388.59%−2,729.27%—
Basic EPSper basic share-$1.11-$1.21-$2.25-$20.28-$26.40-$51.20-$89.80-$84.20
Diluted EPSper diluted share-$1.11-$1.21-$2.25-$20.28-$26.40-$51.20-$89.80-$84.20
Review official source filings ↗

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 2 reported holders of CYCN
HolderShares held
Hecht Peter M
559.28K
Higgins Michael J
30.74K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)1$554.7K disclosed value
1 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Nov 21, 2024Form 4Greenspan David Gerald +1TenPercentOwnerSellCommon Stock, no par value · indirect357.9K$1.55$554.7K0
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about CYCN yet. Start the conversation.

Write the first post